Gilead Sciences
GILD
GILD
1,701 hedge funds and large institutions have $85.8B invested in Gilead Sciences in 2024 Q3 according to their latest regulatory filings, with 168 funds opening new positions, 623 increasing their positions, 690 reducing their positions, and 115 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3% more call options, than puts
Call options by funds: $958M | Put options by funds: $928M
0.89% less ownership
Funds ownership: 83.16% → 82.28% (-0.89%)
10% less repeat investments, than reductions
Existing positions increased: 623 | Existing positions reduced: 690
Holders
1,701
Holding in Top 10
18
Calls
$958M
Puts
$928M
Top Buyers
| 1 | +$1.23B | |
| 2 | +$978M | |
| 3 | +$397M | |
| 4 |
Amundi
Paris,
France
|
+$202M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$150M |
Top Sellers
| 1 | -$596M | |
| 2 | -$550M | |
| 3 | -$316M | |
| 4 |
Two Sigma Investments
New York
|
-$221M |
| 5 |
D.E. Shaw & Co
New York
|
-$218M |